Table 2.
All (n = 792) | Non-obese (n = 369) | MHO (n = 252) | MUO (n = 171) | |||||
---|---|---|---|---|---|---|---|---|
β | p | β | p | β | p | β | p | |
BMI (Kg/m2) | 0.03 | 0.38 | 0.02 | 0.65 | −0.06 | 0.38 | −0.03 | 0.53 |
Waist circumference, cm | 0.01 | 0.84 | 0.02 | 0.69 | 0.01 | 0.98 | 0.08 | 0.21 |
Neck circumference, cm | −0.01 | 0.88 | −0.01 | 0.76 | −0.03 | 0.68 | 0.03 | 0.62 |
Weight gain, kg | −0.04 | 0.37 | 0.04 | 0.76 | −0.08 | 0.44 | −0.01 | 0.90 |
Fasting glucose, mg/dL | 0.08 | 0.03 ΦΧ | 0.08 | 0.14 | −0.05 | 0.63 | 0.32- | <0.001 ΦΩ |
Glycated haemoglobin, % | 0.01 | 0.82 | −0.02 | 0.68 | 0.10 | 0.53 | 0.01 | 0.82 |
Total cholesterol, mg/dL | 0.02 | 0.59 | 0.02 | 0.72 | 0.01 | 0.89 | 0.19 | 0.04 δψ |
HDL-c, mg/dL | 0.05 | 0.15 | 0.09 | 0.12 | 0.05 | 0.60 | 0.13 | 0.16 |
LDL-c, mg/dL | −0.01 | 0.80 | −0.04 | 0.48 | 0.01 | 0.87 | 0.08 | 0.39 |
Triglycerides, mg/dL | 0.04 | 0.26 | 0.07 | 0.27 | −0.08 | 0.30 | 0.33 | 0.001 |
Systolic BP, mm Hg | 0.01 | 0.65 | −0.04 | 0.49 | 0.13 | 0.23 | 0.03 | 0.72 |
Diastolic BP, mm Hg | 0.01 | 0.91 | 0.01 | 0.81 | −0.08 | 0.44 | 0.07 | 0.42 |
ΦMultivariate linear regressions analysis adjusted for age, sex, family income, time of diagnosis of type 2 diabetes mellitus, insulin use, minutes of physical activity per week, mean of sleep time. δMultivariate linear regressions analysis adjusted for age, sex, family income, time of diagnosis of type 2 diabetes mellitus, time of diagnosis of dyslipidaemia, insulin use, use of antidepressants and mean of sleep time. Multivariate linear regressions analysis adjusted for age, sex, family income, employment status, time of diagnosis of dyslipidaemia and use of sleeping pills. Χr2 adjusted = 0.11; Ωr2 adjusted = 0.13; ψr2 adjusted = 0.01; r2adjusted = 0.23. MHO: Metabolically healthy obese. MUO: Metabolically unhealthy obese.